Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood

Lipoproteins play a key role in transport of cholesterol to and from tissues. Recent studies have also demonstrated that red blood cells (RBCs), which carry large quantities of free cholesterol in their membrane, play an important role in reverse cholesterol transport. However, the exact role of RBCs in systemic cholesterol metabolism is poorly understood. RBCs were incubated with autologous plasma or isolated lipoproteins resulting in a significant net amount of cholesterol moved from RBCs to HDL, while cholesterol from LDL moved in the opposite direction. Furthermore, the bi-directional cholesterol transport between RBCs and plasma lipoproteins was saturable and temperature-, energy-, and time-dependent, consistent with an active process. We did not find LDLR, ABCG1, or scavenger receptor class B type 1 in RBCs but found a substantial amount of ABCA1 mRNA and protein. However, specific cholesterol efflux from RBCs to isolated apoA-I was negligible, and ABCA1 silencing with siRNA or inhibition with vanadate and Probucol did not inhibit the efflux to apoA-I, HDL, or plasma. Cholesterol efflux from and cholesterol uptake by RBCs from Abca1+/+ and Abca1−/− mice were similar, arguing against the role of ABCA1 in cholesterol flux between RBCs and lipoproteins. Bioinformatics analysis identified ABCA7, ABCG5, lipoprotein lipase, and mitochondrial translocator protein as possible candidates that may mediate the cholesterol flux. Together, these results suggest that RBCs actively participate in cholesterol transport in the blood, but the role of cholesterol transporters in RBCs remains uncertain.

[1]  H. Low,et al.  Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood. , 2020, Journal of lipid research.

[2]  H. Low,et al.  Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood. , 2020, Journal of lipid research.

[3]  T. Kubota,et al.  Red blood cells participate in reverse cholesterol transport by mediating cholesterol efflux of high-density lipoprotein and apolipoprotein A-I from THP-1 macrophages , 2019, Biological chemistry.

[4]  A. Gotto,et al.  ABCA1-Derived Nascent High-Density Lipoprotein–Apolipoprotein AI and Lipids Metabolically Segregate , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Wiśniewski,et al.  Quantitative Analysis of Human Red Blood Cell Proteome. , 2017, Journal of proteome research.

[6]  Ali Bijani,et al.  Does Serum lipid profile differ in anemia and non-anemic older subjects? , 2017, Caspian journal of internal medicine.

[7]  F. Kuypers,et al.  Featured Article: Depletion of HDL3 high density lipoprotein and altered functionality of HDL2 in blood from sickle cell patients , 2017, Experimental biology and medicine.

[8]  Mark T. Handley,et al.  PLAA Mutations Cause a Lethal Infantile Epileptic Encephalopathy by Disrupting Ubiquitin-Mediated Endolysosomal Degradation of Synaptic Proteins , 2017, American journal of human genetics.

[9]  F. Kuipers,et al.  Transintestinal and Biliary Cholesterol Secretion Both Contribute to Macrophage Reverse Cholesterol Transport in Rats—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[10]  S. Becker,et al.  Cholesterol-mediated allosteric regulation of the mitochondrial translocator protein structure , 2017, Nature Communications.

[11]  M. Nieuwdorp,et al.  Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion. , 2016, Cell metabolism.

[12]  Lingshu Wang,et al.  The Mechanism of Proinflammatory HDL Generation in Sickle Cell Disease Is Linked to Cell-Free Hemoglobin via Haptoglobin , 2016, PloS one.

[13]  H. Low,et al.  Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells. , 2016, Cell reports.

[14]  Jonathan C. Cohen,et al.  Crystal structure of the human sterol transporter ABCG5/ABCG8 , 2016, Nature.

[15]  L. Addadi,et al.  ABCA1 contributes to macrophage deposition of extracellular cholesterol , 2015, Journal of Lipid Research.

[16]  Y. Yamauchi,et al.  Deficiency in the Lipid Exporter ABCA1 Impairs Retrograde Sterol Movement and Disrupts Sterol Sensing at the Endoplasmic Reticulum*♦ , 2015, The Journal of Biological Chemistry.

[17]  B. Wollscheid,et al.  Deep sequencing and proteomic analysis of the microRNA-induced silencing complex in human red blood cells. , 2015, Experimental hematology.

[18]  Hansford C. Hendargo,et al.  Restoration of intracellular ATP production in banked red blood cells improves inducible ATP export and suppresses RBC-endothelial adhesion. , 2014, American Journal of Physiology. Heart and Circulatory Physiology.

[19]  N. Sarrafzadegan,et al.  Association of the Total Cholesterol Content of Erythrocyte Membranes with the Severity of Disease in Stable Coronary Artery Disease , 2014, Cholesterol.

[20]  Jie Zhang,et al.  Mannitol‐adenine‐phosphate: a novel solution for intraoperative blood salvage , 2014, Transfusion.

[21]  J. Shaw,et al.  Plasma lipid profiling in a large population-based cohort[S] , 2013, Journal of Lipid Research.

[22]  S. Gummadi,et al.  Biochemical evidence for lead and mercury induced transbilayer movement of phospholipids mediated by human phospholipid scramblase 1. , 2013, Chemical research in toxicology.

[23]  A. Verhoeven,et al.  The cholesterol content of the erythrocyte membrane is an important determinant of phosphatidylserine exposure. , 2012, Biochimica et biophysica acta.

[24]  Y. Zhong,et al.  Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin , 2012, Upsala journal of medical sciences.

[25]  S. Turner,et al.  Measurement of Reverse Cholesterol Transport Pathways in Humans: In Vivo Rates of Free Cholesterol Efflux, Esterification, and Excretion , 2012, Journal of the American Heart Association.

[26]  Jonathan D. Smith,et al.  Red Blood Cells Play a Role in Reverse Cholesterol Transport , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[27]  N. Friedman,et al.  Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis , 2011, Cell.

[28]  P. Libby,et al.  HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial , 2010, The Lancet.

[29]  A. Yamaguchi,et al.  Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes* , 2009, The Journal of Biological Chemistry.

[30]  J. Volkmer,et al.  Gene expression analysis of human red blood cells , 2009, International journal of medical sciences.

[31]  J. Kaski,et al.  Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? , 2007, Journal of the American College of Cardiology.

[32]  A. Hill,et al.  Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation* , 2007, Journal of Biological Chemistry.

[33]  P. Linsel-Nitschke,et al.  Potential role of ABCA7 in cellular lipid efflux to apoA-I Published, JLR Papers in Press, November 1, 2004. DOI 10.1194/jlr.M400247-JLR200 , 2005, Journal of Lipid Research.

[34]  J. Griffith,et al.  Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. , 2002, Journal of the American College of Cardiology.

[35]  S. K. Kim,et al.  Changes in serum lipid concentrations during iron depletion and after iron supplementation. , 2001, Annals of clinical and laboratory science.

[36]  J. Peterson,et al.  Prostaglandin Levels in Stimulated Macrophages Are Controlled by Phospholipase A2-activating Protein and by Activation of Phospholipase C and D* , 2001, The Journal of Biological Chemistry.

[37]  K. Eckardt,et al.  Cardiovascular consequences of renal anaemia and erythropoietin therapy. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  M C Phillips,et al.  Use of cyclodextrins for manipulating cellular cholesterol content. , 1997, Journal of lipid research.

[39]  D. Sviridov,et al.  Efflux of Cellular Cholesterol and Phospholipid to Apolipoprotein A-I Mutants* , 1996, The Journal of Biological Chemistry.

[40]  J. Frohlich,et al.  Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease. , 1986, Clinical biochemistry.

[41]  S. Quarfordt,et al.  Quantitation of the in vitro free cholesterol exchange of human red cells and lipoproteins. , 1970, Journal of lipid research.

[42]  C. B. Taylor,et al.  The origin of plasma cholesterol and the rates of equilibration of liver, plasma, and erythrocyte cholesterol. , 1955, The Journal of laboratory and clinical medicine.

[43]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[44]  G. Anderluh,et al.  Kinetics of cholesterol extraction from lipid membranes by methyl-beta-cyclodextrin--a surface plasmon resonance approach. , 2008, Biochimica et biophysica acta.